Public procurement notice: Contract Award Notice
Published: 2024-06-25
Buyer: SYKEHUSINNKJØP HF
Country: NO
Region: NO074
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 16800000 NOK
Submission deadline: 2027-01-30
Award criteria: quality, price

Technical requirements: Sykehusinnkjøp HF, division pharmaceuticals, is collecting tenders for medicines that are used in the specialist health service. It has previously been announced and held an open tender contest for 2501a anti-infectives. The competition included active substances in accordance with the tender documentation annex 2 - Price Form.After the implementation of the competition, tenders have been submitted for the product stated active ingredient list, where the tenderer has been given marketing permission. See the Medicines Act § 8 and the medicines regulations § 2-1 first and second paragraphs, where, as a main rule, there are requirements for marketing permits before the turnover of medicines can occur. There were no other tenderers in this competition for the lot in question (lot 54, J01EE01Sulfametoksazol, Trimetoprim) Based on this, Sykehusinnkjøp HF intends to enter into agreements between the regional health companies (the Contracting Authorities) and Macure Pharma ApS as an additional contract to 2501a anti-infectives i.e. the extent and duration of the agreement shall follow the mentioned procurement (including access to extensions and termination),  without a new competition for this active ingredient being announced. The health authorities that are subject to the regional health authorities have an option to join the agreement. The same applies to ideal institutions/hospitals with operational agreements with each health region. Sykehusinnkjøp HF, division medicines have examined the market situation and assess that it is not possible with a new competition or that another supplier than the mentioned supplier can deliver the products in the impending contract period, and that the situation that has arisen is conditions that are not due to the contracting authorities or that the contracting authorities could predict. Sykehusinnkjøp HF therefore believes that it is necessary to implement the procurement without a competition. See the procurement regulations §21-5, cf. § 21-2, cf. § 13-4 letter b no. 3 and letter cf. also §13-3 letter e.Sykehusinnkjøp HF asks those who may have objections to this intention of giving feedback by the expiry of the waiting period, which is set to 05.07.2024. If objections are not received, contracts will be signed after the waiting period has expired.
Sykehusinnkjøp HF, division pharmaceuticals, is collecting tenders for medicines that are used in the specialist health service. It has previously been announced and held an open tender contest for 2501a anti-infectives. The competition included active substances in accordance with the tender documentation's annex 2 - Price Form.
At the end of the Contract period, the Contracting Authority can extend all or parts of the Contract for up to 1 year if 
Time. The total maximum agreement period is 4 years.


Number of bids: 1